Answers are grounded in this paper and cite their sources.
The Association of Plasma Asymmetric Dimethylarginine Concentrations and Inflammation Markers in Non-small Cell Lung Cancer L ung cancer is one of the leading causes of cancer-relat- ed deaths and non-small cell lung cancer type (NSCLC) constitutes approximately 85% of all cases. [1]As tobacco use is increasing all around the world, smoking leads to 80% of lung cancer deaths. [2]More than half of the patients with NSCLC cannot be often diagnosed until its advanced stages or developing distant metastases. [2]World Health Organization categorized the subtypes of NSCLC as adeno-Objectives: Nonsmall cell lung cancer (NSCLC) accounts for about 85% of all lung cancers.Asymmetric dimethylarginine (ADMA) is an emerging molecule that is highlighted in carcinogenesis and tumor progression in lung cancer.Since elevated concentrations of ADMA are observed in lung cancer patients, we aimed to explore its associations with inflammation markers and established prognostic indices.Methods: 78 newly diagnosed non-small cell lung cancer patients who were presented with brain metastases at the initial admission and 41 Stage 1 patients with NSCLC were included in the study.ADMA concentrations among the groups were correlated.Further, the relationship between ADMA levels and the other inflammatory markers was analyzed.Results: ADMA levels were significantly higher in the group of NSCLC patients with brain metastases than in the Stage 1 patients control group (p<0.001).A significant negative correlation was found between ADMA levels and BMI, albumin and hemoglobin (p<0.001),whereas it was positively correlated with platelet, WBC, neutrophil-to-lymphocyte ratio, RDW, RDW/albumin ratio, LDH, CRP, fibrinogen, platelet, and CRP/albumin ratio (p<0.001).Conclusion: Increased circulating concentrations of ADMA were significantly correlated with higher NLR, CRP and LDH; which were accepted as indicators of poor prognosis in NSCLC patients.ADMA might contribute to tumor growth and dissemination via systemic inflammatory pathways.
No takes yet. Share an insight, caveat, or question.
Müfide Arzu Özkarafakılı (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: